Tesamorelin
peptide · evidence: established · v1.0.0
Description
GHRH analog; established pharmaceutical in specific indications.
Mechanism summary
GHRH receptor agonist; GH axis modulation.
Reference details
Route(s): subcutaneous
Tags: hormone, metabolic
Active: yes
Dosing references (verbatim from source — not recommendations)
1-2 mg SC daily at bedtime
once daily at bedtime · 12+ weeks · Continuous per provider direction · subcutaneous
Source: Practitioner Peptide Dosing Reference (commonly published ranges) — Compiled practitioner reference (internal_protocol) · not yet provider-reviewed
Provider-only reference. This page does not constitute medical advice, a recommendation, or dosing guidance.